The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes.

Protein degradation by the proteasome plays an important role in all major cellular pathways. Aberrant proteasome activity is associated with numerous human diseases including cancer and neurological disorders, but the underlying mechanism is virtually unclear. At least part of the reason for this is due to lack of understanding of the regulation of human proteasome genes. In this study, we found that a large set of human proteasome genes carry the CCAAT box in their promoters. We further demonstrated that the basal expression of these CCAAT box-containing proteasome genes is regulated by the transcription factor NF-Y. Knockdown of NF-YA, an essential subunit of NF-Y, reduced proteasome gene expression and compromised the cellular proteasome activity. In addition, we showed that knockdown of NF-YA sensitized breast cancer cells to the proteasome inhibitor MG132. This study unveils a new role for NF-Y in the regulation of human proteasome genes and suggests that NF-Y may be a potential target for cancer therapy.

[1]  F. Guadagni,et al.  Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. , 2003, Molecular biology of the cell.

[2]  E. Lightcap,et al.  Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib. , 2010, Cancer research.

[3]  F. C. Lucibello,et al.  Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. , 1995, The EMBO journal.

[4]  M. Yano,et al.  RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis , 2004, Journal of Cell Science.

[5]  A. Varshavsky,et al.  RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: A negative feedback circuit , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Masson,et al.  Use of RNA Interference and Complementation To Study the Function of the Drosophila and Human 26S Proteasome Subunit S13 , 2003, Molecular and Cellular Biology.

[7]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[8]  A. Fagan,et al.  A proteasomal stress response: pre‐treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury , 2004, Journal of neurochemistry.

[9]  Hiroshi Handa,et al.  NF-Y Is Essential for the Recruitment of RNA Polymerase II and Inducible Transcription of Several CCAAT Box-Containing Genes , 2005, Molecular and Cellular Biology.

[10]  F. C. Lucibello,et al.  Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. , 1995, Nucleic acids research.

[11]  R. Mantovani,et al.  The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.

[12]  P. Young,et al.  Basic Leucine Zipper Protein Cnc-C Is a Substrate and Transcriptional Regulator of the Drosophila 26S Proteasome , 2010, Molecular and Cellular Biology.

[13]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[14]  A. Ewis,et al.  Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster. , 2009, Biochemical and Biophysical Research Communications - BBRC.

[15]  C. Geismann,et al.  Inflammatory Macrophages Induce Nrf2 Transcription Factor-dependent Proteasome Activity in Colonic NCM460 Cells and Thereby Confer Anti-apoptotic Protection* , 2011, The Journal of Biological Chemistry.

[16]  H. Feldmann,et al.  Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast , 1999, FEBS letters.

[17]  R. Wadhwa,et al.  Preincubation with the Proteasome Inhibitor MG‐132 Enhances Proteasome Activity via the Nrf2 Transcription Factor in Aging Human Skin Fibroblasts , 2006, Annals of the New York Academy of Sciences.

[18]  Youming Xie.  Feedback regulation of proteasome gene expression and its implications in cancer therapy , 2010, Cancer and Metastasis Reviews.

[19]  Robert Huber,et al.  Molecular Machines for Protein Degradation , 2005, Chembiochem : a European journal of chemical biology.

[20]  M. Kwak,et al.  Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway , 2003, Molecular and Cellular Biology.

[21]  Donghong Ju,et al.  Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells , 2007, Breast Cancer Research and Treatment.

[22]  X. Mao,et al.  Homeostatic regulation of the proteasome via an Rpn4-dependent feedback circuit. , 2004, Biochemical and biophysical research communications.

[23]  M. Tiainen,et al.  Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex , 1999, Oncogene.

[24]  K. Tanaka,et al.  Abnormally high expression of proteasomes in human leukemic cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Donghong Ju,et al.  Inhibition of Proteasomal Degradation of Rpn4 Impairs Nonhomologous End-Joining Repair of DNA Double-Strand Breaks , 2010, PloS one.

[26]  W. Baumeister,et al.  A Subcomplex of the Proteasome Regulatory Particle Required for Ubiquitin-Conjugate Degradation and Related to the COP9-Signalosome and eIF3 , 1998, Cell.

[27]  E. Krüger,et al.  Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. , 2010, Molecular cell.

[28]  R. Deshaies,et al.  Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. , 2010, Molecular cell.

[29]  Qiongyu Chen,et al.  Nuclear Factor Y Is Required for Basal Activation and Chromatin Accessibility of Fibroblast Growth Factor Receptor 2 Promoter in Osteoblast-like Cells*S⃞ , 2009, Journal of Biological Chemistry.

[30]  Friedrich Förster,et al.  Insights into the molecular architecture of the 26S proteasome , 2009, Proceedings of the National Academy of Sciences.

[31]  A Ciechanover,et al.  The ubiquitin-proteasome pathway and pathogenesis of human diseases. , 1999, Annual review of medicine.

[32]  A. Ciechanover,et al.  Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. , 2009, Annual review of pharmacology and toxicology.

[33]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[34]  Li Chen,et al.  Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. , 2005, Cancer research.

[35]  J. Hampe,et al.  Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) , 2009, Oncogene.

[36]  P. C. Ramos,et al.  Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome , 2004, FEBS letters.

[37]  C. Pilarsky,et al.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. , 2004, Neoplasia.

[38]  F. Miller,et al.  MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.

[39]  F. Martelli,et al.  Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation. , 2010, Cancer research.

[40]  G. Demartino,et al.  Analysis of Drosophila 26 S Proteasome Using RNA Interference* , 2002, The Journal of Biological Chemistry.

[41]  F. Desmots,et al.  Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability , 2010, Oncogene.

[42]  Morgan Sheng,et al.  Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease , 2011, Neuron.

[43]  Donghong Ju,et al.  Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells. , 2009, International journal of molecular medicine.

[44]  M. Gorovsky,et al.  Mapping the 5' and 3' ends of Tetrahymena thermophila mRNAs using RNA ligase mediated amplification of cDNA ends (RLM-RACE). , 1993, Nucleic acids research.

[45]  E. Huang,et al.  Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration , 2011, Proceedings of the National Academy of Sciences.

[46]  Giulia Piaggio,et al.  Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity. , 2008, Molecular biology of the cell.

[47]  P. Kloetzel,et al.  Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes* , 2003, Journal of Biological Chemistry.

[48]  Donghong Ju,et al.  Proteasomal Degradation of Rpn4 in Saccharomyces cerevisiae Is Critical for Cell Viability Under Stressed Conditions , 2010, Genetics.

[49]  R. Müller,et al.  Cell cycle regulation of the murine cdc25B promoter: essential role for nuclear factor-Y and a proximal repressor element. , 2001, The Journal of biological chemistry.

[50]  Donghong Ju,et al.  Disruption of Rpn4-Induced Proteasome Expression in Saccharomyces cerevisiae Reduces Cell Viability Under Stressed Conditions , 2008, Genetics.